BLCM
Bellicum Pharmaceuticals, Inc.
BLCM
BLCM
Delisted
BLCM was delisted on the 1st of June, 2023.
71 hedge funds and large institutions have $340M invested in Bellicum Pharmaceuticals, Inc. in 2015 Q1 according to their latest regulatory filings, with 34 funds opening new positions, 11 increasing their positions, 17 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
35% less repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 17
94% less call options, than puts
Call options by funds: $23K | Put options by funds: $394K
Holders
71
Holding in Top 10
2
Calls
$23K
Puts
$394K
Top Buyers
| 1 | +$10.9M | |
| 2 | +$8.51M | |
| 3 | +$5.91M | |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$5.42M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$4.08M |
Top Sellers
| 1 | -$8.67M | |
| 2 | -$3.92M | |
| 3 | -$2.88M | |
| 4 |
Morgan Stanley
New York
|
-$2.7M |
| 5 |
FCMI
Foresite Capital Management II
Larkspur,
California
|
-$2.42M |